Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) has announced a three-year contract with a leading global medical technology company, marking another Fortune 500 win for the Toronto-based software supply chain security firm. The deal was awarded following an extensive competitive procurement evaluation, with the customer selecting Cybeats for its SBOM and vulnerability management capabilities. The announcement signals continued momentum in the medical device sector, where FDA regulatory requirements are generating growing demand for robust software transparency solutions.

Key Points

  • Cybeats Technologies Corp. (CSE: CYBT / OTCQB: CYBCF) announced the new enterprise contract on October 22, 2026.
  • A three-year agreement was signed with an unnamed global Fortune 500 medical technology company following a competitive procurement process.
  • The contract value was not disclosed in the announcement.
  • Investors may be watching whether this deal translates into further enterprise wins as FDA SBOM requirements drive sector demand.

Competitive Selection Process and FDA-Driven Demand in Medical Devices

According to the release, Cybeats was chosen following an extensive procurement evaluation, with the unnamed customer citing the company's advanced SBOM and vulnerability management capabilities in highly regulated operational environments. The disclosure notes that FDA regulatory requirements are driving demand for SBOM documentation during premarket submissions, as well as ongoing vulnerability monitoring throughout a product's lifecycle. The announcement references recent vulnerabilities such as PHP2Shell as an example of why software supply chain visibility is increasingly critical for medical device makers operating complex software ecosystems.

CEO Commentary and Pipeline Growth

CEO Justin Leger stated in the release that the customer committed to a three-year term following an extensive competitive process. Leger described the company's pipeline as "larger than ever" and noted continued progress across its partner ecosystem, including deals in new geographies. He also indicated that the partner ecosystem is accelerating market access beyond what the company could achieve on a standalone basis. The company did not disclose specific pipeline figures, geographic details, or financial guidance in conjunction with these comments.

Cybeats SBOM Studio and the RAVEN Intelligence Layer

The announcement describes Cybeats SBOM Studio as the company's core SBOM system of record for software supply chain security, offering governed, audit-ready software transparency across the software lifecycle. Built on SBOM Studio, RAVEN is Cybeats' AI-native intelligence layer, designed to deliver vulnerability prioritisation, reachability analysis, and evidence-based decision support. The platform targets critical infrastructure sectors including healthcare, medical devices, energy, automotive, financial services, and defence, positioning Cybeats as a broad-based enterprise cybersecurity provider rather than a single-vertical specialist.

Immediate Share Price Impact

The immediate share price impact was not clear from available public information. Investors may be watching how the company's expanding Fortune 500 customer base and growing partner ecosystem are reflected in future financial results, particularly as the medical device sector continues to face heightened regulatory scrutiny around software supply chain security under evolving FDA guidance.